Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Non Operating Income (2020 - 2025)

iSpecimen has reported Non Operating Income over the past 6 years, most recently at -$2.3 million for Q4 2025.

  • Quarterly results put Non Operating Income at -$2.3 million for Q4 2025, down 1021.06% from a year ago — trailing twelve months through Dec 2025 was -$1.5 million (down 838.95% YoY), and the annual figure for FY2025 was -$1.5 million, down 755.67%.
  • Non Operating Income for Q4 2025 was -$2.3 million at iSpecimen, down from $49574.0 in the prior quarter.
  • Over the last five years, Non Operating Income for ISPC hit a ceiling of $1.6 million in Q4 2023 and a floor of -$3.0 million in Q1 2021.
  • Median Non Operating Income over the past 5 years was $2626.0 (2022), compared with a mean of -$136097.2.
  • Biggest five-year swings in Non Operating Income: soared 61954.7% in 2024 and later plummeted 1021.06% in 2025.
  • iSpecimen's Non Operating Income stood at -$55389.0 in 2021, then soared by 193.1% to $51565.0 in 2022, then soared by 3057.19% to $1.6 million in 2023, then crashed by 112.68% to -$206355.0 in 2024, then plummeted by 1021.06% to -$2.3 million in 2025.
  • The last three reported values for Non Operating Income were -$2.3 million (Q4 2025), $49574.0 (Q3 2025), and $764165.0 (Q2 2025) per Business Quant data.